287979-27-5 Usage
General Description
6-(2,2,2-Trifluoroethoxy)nicotinic acid methyl ester is a chemical compound typically used in the research and development process of the pharmaceutical industry. The structure contains a nicotinic acid (vitamin B3) backbone with a trifluoroethoxy group attached, enhancing its potential biological activity. Because of this, it may serve as a significant component in the synthesis of various potential therapeutic agents. It's an ester - a class of organic compounds that react with water to produce alcohols and organic or inorganic acids. Like other chemicals, it should be handled with care to ensure safety. Specific properties, such as its exact chemical structuring, physical properties, possible toxicity, and handling methods, must be defined by additional research and documented in material safety data sheets.
Check Digit Verification of cas no
The CAS Registry Mumber 287979-27-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,7,9,7 and 9 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 287979-27:
(8*2)+(7*8)+(6*7)+(5*9)+(4*7)+(3*9)+(2*2)+(1*7)=225
225 % 10 = 5
So 287979-27-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H8F3NO3/c1-15-8(14)6-2-3-7(13-4-6)16-5-9(10,11)12/h2-4H,5H2,1H3
287979-27-5Relevant articles and documents
AZETIDINE COMPOUNDS AS GRP119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS
-
Paragraph 0256, (2018/09/12)
The present disclosure relates to azetidine compounds. The azetidine compounds are GPR119 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The present disclosure furthermore relates to the use of azetidine compounds as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.
